Anti-Cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: An In-Vivo Study
Pharmaceutical Research - United States
doi 10.1007/s11095-016-2015-0
Full Text
Open PDFAbstract
Available in full text
Date
August 15, 2016
Authors
Publisher
Springer Science and Business Media LLC